应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
MXCT MaxCyte Inc
休市中 04-02 16:00:00 EDT
0.7496
+0.0055
+0.74%
盘后
0.7500
+0.0004
+0.05%
17:51 EDT
最高
0.7516
最低
0.7098
成交量
149.78万
今开
0.7112
昨收
0.7441
日振幅
5.62%
总市值
7,996万
流通市值
7,209万
总股本
1.07亿
成交额
109.39万
换手率
1.56%
流通股本
9,617万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Maxcyte, Inc.盘中异动 急速跳水5.15%报0.693美元
市场透视 · 02-13
Maxcyte, Inc.盘中异动 急速跳水5.15%报0.693美元
Maxcyte, Inc.盘中异动 快速上涨5.08%
市场透视 · 01-16
Maxcyte, Inc.盘中异动 快速上涨5.08%
MaxCyte宣布2026年首席财务官过渡计划
投资观察 · 2025-11-20
MaxCyte宣布2026年首席财务官过渡计划
MaxCyte第三季度收入为640万美元，低于IBES预期的837万美元
投资观察 · 2025-11-20
MaxCyte第三季度收入为640万美元，低于IBES预期的837万美元
MaxCyte Inc宣布与Moonlight Bio达成战略平台许可协议，共同推进实体瘤T细胞疗法开发
美股速递 · 2025-10-06
MaxCyte Inc宣布与Moonlight Bio达成战略平台许可协议，共同推进实体瘤T细胞疗法开发
Maxcyte, Inc.盘中异动 快速下跌5.13%
市场透视 · 2025-03-11
Maxcyte, Inc.盘中异动 快速下跌5.13%
Maxcyte, Inc.盘中异动 下午盘股价大跌5.52%
市场透视 · 2025-02-27
Maxcyte, Inc.盘中异动 下午盘股价大跌5.52%
Maxcyte, Inc.盘中异动 早盘急速上涨5.31%
市场透视 · 2025-02-25
Maxcyte, Inc.盘中异动 早盘急速上涨5.31%
Maxcyte, Inc.盘中异动 下午盘股价大跌5.04%报3.96美元
市场透视 · 2025-02-19
Maxcyte, Inc.盘中异动 下午盘股价大跌5.04%报3.96美元
Maxcyte, Inc.盘中异动 早盘急速上涨5.41%
市场透视 · 2025-02-14
Maxcyte, Inc.盘中异动 早盘急速上涨5.41%
Maxcyte, Inc.盘中异动 股价大跌5.05%
市场透视 · 2025-02-12
Maxcyte, Inc.盘中异动 股价大跌5.05%
Maxcyte, Inc.盘中异动 股价大跌5.10%
市场透视 · 2025-02-03
Maxcyte, Inc.盘中异动 股价大跌5.10%
Maxcyte, Inc.盘中异动 股价大涨5.17%报4.88美元
市场透视 · 2025-01-30
Maxcyte, Inc.盘中异动 股价大涨5.17%报4.88美元
【纳斯达克生物科技指数收涨超1.6%】成分股Precigen收涨18.58%，阿玛琳涨16.17%，Grail涨14.71%表现第三、并领跑纳斯达克100指数的成分股。MaxCyte则收跌5.93%，跌幅第三大，10X Genomics跌8.65%，Pacific Biosciences of California跌8.84%。
金融界 · 2025-01-24
【纳斯达克生物科技指数收涨超1.6%】成分股Precigen收涨18.58%，阿玛琳涨16.17%，Grail涨14.71%表现第三、并领跑纳斯达克100指数的成分股。MaxCyte则收跌5.93%，跌幅第三大，10X Genomics跌8.65%，Pacific Biosciences of California跌8.84%。
Maxcyte, Inc.盘中异动 股价大跌5.14%报4.80美元
市场透视 · 2025-01-24
Maxcyte, Inc.盘中异动 股价大跌5.14%报4.80美元
Maxcyte, Inc.盘中异动 股价大涨5.05%
市场透视 · 2025-01-17
Maxcyte, Inc.盘中异动 股价大涨5.05%
Maxcyte, Inc.盘中异动 早盘股价大涨5.60%
市场透视 · 2025-01-15
Maxcyte, Inc.盘中异动 早盘股价大涨5.60%
Maxcyte, Inc.盘中异动 股价大跌5.30%报4.65美元
市场透视 · 2025-01-15
Maxcyte, Inc.盘中异动 股价大跌5.30%报4.65美元
Maxcyte, Inc.盘中异动 早盘大幅上涨5.68%
市场透视 · 2025-01-13
Maxcyte, Inc.盘中异动 早盘大幅上涨5.68%
Maxcyte, Inc.盘中异动 股价大跌5.69%
市场透视 · 2025-01-10
Maxcyte, Inc.盘中异动 股价大跌5.69%
加载更多
公司概况
公司名称：
MaxCyte Inc
所属市场：
NASDAQ
上市日期：
--
主营业务：
MaxCyte, Inc.于1998年7月31日根据特拉华州的法律和规定成立。该公司是一家领先的商业细胞工程公司，提供其专有的流式电穿孔技术平台，以支持下一代细胞疗法的发现、开发和商业化。其ExPERT平台支持从研究到商业化生产的细胞治疗领域广泛应用。
发行价格：
--
{"stockData":{"symbol":"MXCT","market":"US","secType":"STK","nameCN":"MaxCyte Inc","latestPrice":0.7496,"timestamp":1775160000000,"preClose":0.7441,"halted":0,"volume":1497823,"hourTrading":{"tag":"盘后","latestPrice":0.75,"preClose":0.7496,"latestTime":"17:51 EDT","volume":2601,"amount":1951.0072,"timestamp":1775166687948,"change":0.0004,"changeRate":0.000534,"amplitude":0.000534},"delay":0,"changeRate":0.007391479639833437,"floatShares":96174451,"shares":106674011,"eps":-0.42,"marketStatus":"休市中","change":0.0055,"latestTime":"04-02 16:00:00 EDT","open":0.7112,"high":0.7516,"low":0.7098,"amount":1093908.548814,"amplitude":0.056175,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.42,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1775462400000},"marketStatusCode":7,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":0.7441,"preHourTrading":{"tag":"盘前","latestPrice":0.712,"preClose":0.7441,"latestTime":"09:27 EDT","volume":2417,"amount":1733.6496869500002,"timestamp":1775136470080,"change":-0.0321,"changeRate":-0.043139,"amplitude":0.043139},"postHourTrading":{"tag":"盘后","latestPrice":0.75,"preClose":0.7496,"latestTime":"17:51 EDT","volume":2601,"amount":1951.0072,"timestamp":1775166687948,"change":0.0004,"changeRate":0.000534,"amplitude":0.000534},"volumeRatio":1.2724827866600674,"impliedVol":1.4534,"impliedVolPercentile":0.8606},"requestUrl":"/m/hq/s/MXCT","defaultTab":"news","newsList":[{"id":"2611719329","title":"Maxcyte, Inc.盘中异动 急速跳水5.15%报0.693美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611719329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611719329?lang=zh_cn&edition=full","pubTime":"2026-02-13 01:04","pubTimestamp":1770915854,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日01时04分，Maxcyte, Inc.股票出现波动，股价大幅下跌5.15%。截至发稿，该股报0.693美元/股，成交量49.7639万股，换手率0.47%，振幅5.89%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.06%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213010415a6f432e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213010415a6f432e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","MXCT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603959492","title":"Maxcyte, Inc.盘中异动 快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603959492","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603959492?lang=zh_cn&edition=full","pubTime":"2026-01-16 01:09","pubTimestamp":1768496964,"startTime":"0","endTime":"0","summary":"北京时间2026年01月16日01时09分，Maxcyte, Inc.股票出现波动，股价快速拉升5.08%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.02%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116010924a71f6f37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116010924a71f6f37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MXCT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196533798","title":"MaxCyte宣布2026年首席财务官过渡计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1196533798","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196533798?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:30","pubTimestamp":1763573428,"startTime":"0","endTime":"0","summary":"11月12日 - MaxCyte Inc：*MAXCYTE宣布2026年首席财务官过渡计划*MAXCYTE INC - 首席财务官DOUGLAS SWIRSKY将在2026年进行角色过渡*MAXCYTE INC - SWIRSKY将在任命继任者之前继续担任首席财务官","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4539","MXCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163285225","title":"MaxCyte第三季度收入为640万美元，低于IBES预期的837万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163285225","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163285225?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:43","pubTimestamp":1763570621,"startTime":"0","endTime":"0","summary":"11月5日消息 - MaxCyte第三季度现金及投资总额为1.58亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","MXCT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196718221","title":"MaxCyte Inc宣布与Moonlight Bio达成战略平台许可协议，共同推进实体瘤T细胞疗法开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1196718221","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196718221?lang=zh_cn&edition=full","pubTime":"2025-10-06 20:06","pubTimestamp":1759752401,"startTime":"0","endTime":"0","summary":"MaxCyte Inc宣布与Moonlight Bio达成战略平台许可协议，共同推进实体瘤T细胞疗法开发","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","MXCT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518546788","title":"Maxcyte, Inc.盘中异动 快速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518546788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518546788?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:40","pubTimestamp":1741632016,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时40分，Maxcyte, Inc.股票出现波动，股价急速跳水5.13%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为1.64%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102401698a2d8b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102401698a2d8b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4539","MXCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514866134","title":"Maxcyte, Inc.盘中异动 下午盘股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514866134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514866134?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:12","pubTimestamp":1740593537,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时12分，Maxcyte, Inc.股票出现异动，股价急速下挫5.52%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.69%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702121896317881&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702121896317881&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4539","MXCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514126090","title":"Maxcyte, Inc.盘中异动 早盘急速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514126090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514126090?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493874,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Maxcyte, Inc.股票出现异动，股价快速拉升5.31%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.05%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522311598924c4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522311598924c4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4539","MXCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512719648","title":"Maxcyte, Inc.盘中异动 下午盘股价大跌5.04%报3.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512719648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512719648?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:16","pubTimestamp":1739906209,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时16分，Maxcyte, Inc.股票出现波动，股价快速下挫5.04%。截至发稿，该股报3.96美元/股，成交量34.6713万股，换手率0.33%，振幅5.88%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.65%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031650988a2a64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031650988a2a64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4121","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511369488","title":"Maxcyte, Inc.盘中异动 早盘急速上涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511369488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511369488?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:10","pubTimestamp":1739545855,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时10分，Maxcyte, Inc.股票出现波动，股价大幅上涨5.41%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.10%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231055962324a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231055962324a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510615332","title":"Maxcyte, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510615332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510615332?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:03","pubTimestamp":1739293432,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日01时03分，Maxcyte, Inc.股票出现波动，股价大幅跳水5.05%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.38%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212010352961f61b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212010352961f61b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4539","MXCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508359142","title":"Maxcyte, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508359142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508359142?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:13","pubTimestamp":1738595637,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时13分，Maxcyte, Inc.股票出现波动，股价大幅跳水5.10%。截至发稿，该股报4.28美元/股，成交量10.2101万股，换手率0.10%，振幅2.00%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.68%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231357abc11094&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231357abc11094&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507621625","title":"Maxcyte, Inc.盘中异动 股价大涨5.17%报4.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507621625?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:34","pubTimestamp":1738247685,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时34分，Maxcyte, Inc.股票出现异动，股价急速上涨5.17%。截至发稿，该股报4.88美元/股，成交量2.4515万股，换手率0.02%，振幅3.45%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.62%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302234459876b1ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302234459876b1ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505024850","title":"【纳斯达克生物科技指数收涨超1.6%】成分股Precigen收涨18.58%，阿玛琳涨16.17%，Grail涨14.71%表现第三、并领跑纳斯达克100指数的成分股。MaxCyte则收跌5.93%，跌幅第三大，10X Genomics跌8.65%，Pacific Biosciences of California跌8.84%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2505024850","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505024850?lang=zh_cn&edition=full","pubTime":"2025-01-24 05:50","pubTimestamp":1737669036,"startTime":"0","endTime":"0","summary":"成分股Precigen收涨18.58%，阿玛琳涨16.17%，Grail涨14.71%表现第三、并领跑纳斯达克100指数的成分股。MaxCyte则收跌5.93%，跌幅第三大，10X Genomics跌8.65%，Pacific Biosciences of California跌8.84%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/24055047770352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NDX","159632","AMRN","BK4585","NVIW.SI","BK4539","SQQQ","ARTL","QID","MXCT","BK4588","159837","BK1147","BK4139","PSQ","NQmain","USAW.SI","03086","MNQmain",".IXIC","BK4007","BK4121","PGEN","PACB","TSYW.SI","QLD","TQQQ","USJW.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505499590","title":"Maxcyte, Inc.盘中异动 股价大跌5.14%报4.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505499590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505499590?lang=zh_cn&edition=full","pubTime":"2025-01-24 01:28","pubTimestamp":1737653294,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日01时28分，Maxcyte, Inc.股票出现异动，股价大幅下跌5.14%。截至发稿，该股报4.80美元/股，成交量46.0469万股，换手率0.44%，振幅5.43%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.56%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124012815a22d2d8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124012815a22d2d8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4539","MXCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504219877","title":"Maxcyte, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504219877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504219877?lang=zh_cn&edition=full","pubTime":"2025-01-17 23:43","pubTimestamp":1737128603,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日23时43分，Maxcyte, Inc.股票出现异动，股价大幅拉升5.05%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.02%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501172343239607a942&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501172343239607a942&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4121","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503640987","title":"Maxcyte, Inc.盘中异动 早盘股价大涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503640987?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:40","pubTimestamp":1736952037,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时40分，Maxcyte, Inc.股票出现波动，股价大幅上涨5.60%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.72%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152240389604b6cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152240389604b6cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503726505","title":"Maxcyte, Inc.盘中异动 股价大跌5.30%报4.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503726505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503726505?lang=zh_cn&edition=full","pubTime":"2025-01-15 00:34","pubTimestamp":1736872496,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日00时34分，Maxcyte, Inc.股票出现异动，股价急速跳水5.30%。截至发稿，该股报4.65美元/股，成交量35.8864万股，换手率0.34%，振幅8.66%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.01%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011500345696039490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011500345696039490&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503558585","title":"Maxcyte, Inc.盘中异动 早盘大幅上涨5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503558585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503558585?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:32","pubTimestamp":1736778770,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时32分，Maxcyte, Inc.股票出现异动，股价大幅拉升5.68%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.50%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132232509602530c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132232509602530c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4121","MXCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502893632","title":"Maxcyte, Inc.盘中异动 股价大跌5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502893632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502893632?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:58","pubTimestamp":1736521118,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时58分，Maxcyte, Inc.股票出现异动，股价快速下挫5.69%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.22%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011022583995ff7438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011022583995ff7438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4539","MXCT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.maxcyte.com","stockEarnings":[{"period":"1week","weight":0.0458},{"period":"1month","weight":-0.0139},{"period":"3month","weight":-0.5164},{"period":"6month","weight":-0.5616},{"period":"1year","weight":-0.7284},{"period":"ytd","weight":-0.5164}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":-0.036},{"period":"3month","weight":-0.04},{"period":"6month","weight":-0.02},{"period":"1year","weight":0.1617},{"period":"ytd","weight":-0.0383}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MaxCyte, Inc.于1998年7月31日根据特拉华州的法律和规定成立。该公司是一家领先的商业细胞工程公司，提供其专有的流式电穿孔技术平台，以支持下一代细胞疗法的发现、开发和商业化。其ExPERT平台支持从研究到商业化生产的细胞治疗领域广泛应用。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.10886},{"month":2,"riseRate":0.2,"avgChangeRate":-0.121242},{"month":3,"riseRate":0.4,"avgChangeRate":-0.062251},{"month":4,"riseRate":0.6,"avgChangeRate":-0.04473},{"month":5,"riseRate":0.25,"avgChangeRate":-0.06992},{"month":6,"riseRate":0.5,"avgChangeRate":-0.014501},{"month":7,"riseRate":0.5,"avgChangeRate":0.07388},{"month":8,"riseRate":0,"avgChangeRate":-0.149759},{"month":9,"riseRate":0.4,"avgChangeRate":-0.013093},{"month":10,"riseRate":0.2,"avgChangeRate":-0.034224},{"month":11,"riseRate":0.4,"avgChangeRate":0.098543},{"month":12,"riseRate":0.4,"avgChangeRate":-0.00509}],"exchange":"NASDAQ","name":"MaxCyte Inc","nameEN":"MaxCyte Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MaxCyte Inc(MXCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MaxCyte Inc(MXCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MaxCyte Inc,MXCT,MaxCyte Inc股票,MaxCyte Inc股票老虎,MaxCyte Inc股票老虎国际,MaxCyte Inc行情,MaxCyte Inc股票行情,MaxCyte Inc股价,MaxCyte Inc股市,MaxCyte Inc股票价格,MaxCyte Inc股票交易,MaxCyte Inc股票购买,MaxCyte Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MaxCyte Inc(MXCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MaxCyte Inc(MXCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}